
Opinion|Videos|April 4, 2025
Future Breakthroughs: What’s Next for Bispecific Antibodies in Oncology?
Experts discuss innovations and advancements in bispecific antibodies that could transform their use in the next 5 years.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What innovations or advancements in bispecific antibodies could transform their use in the next 5 years?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care
2
Semaglutide Shows Promise for Steatohepatitis Resolution in MASH
3
Socioeconomic Factors Linked to Surgical Outcomes in Upper Extremity Soft Tissue Sarcoma
4
FDA Draft Guidance Proposes CR, MRD to Accelerate MM Drug Approval
5






























































